“…Currently, there are limited outcomes data on SCS for various chronic visceral pain syndromes. What limited data exist in the literature are in the form of case reports and smaller case series that demonstrate significant clinical improvement in patients with chronic visceral syndromes: mesenteric ischemic pain , esophageal dysmotility , gastroparesis , irritable bowel syndrome (IBS) , chronic pancreatitis , familial Mediterranean fever , posttraumatic splenectomy , generalized chronic abdominal pain , chronic mesenteric ischemia , and chronic visceral pelvic pain . A recent small prospective randomized crossover study on IBS patients receiving SCS demonstrated significant pain relief with SCS .…”